Olopatadine HCL 0.1% eye drops 5ML
Ended Awarded
- Contract number
- SPE2DB26FM8RL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,048
Award facts
- Contract value 100% obligated
- $1,048.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Olopatadine HCL 0.1% eye drops in 5ML units, with a ceiling value of $1,048.25. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. The contract is scheduled for ultimate completion on October 16, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's expansive IDC vehicle enables it to supply a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including customers such as the Defense Health Agency and the U.S. Coast Guard. This particular delivery order for ophthalmic medication represents a routine procurement transaction under the broader pharmaceutical supply arrangement, consistent with AmerisourceBergen's established pattern of fulfilling diverse federal medical supply requirements through firm fixed-price delivery orders.
Quick answers
Who was awarded contract SPE2DB26FM8RL?
SPE2DB26FM8RL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 15, 2025.
How much is contract SPE2DB26FM8RL worth?
The government has obligated $1,048 on SPE2DB26FM8RL.
Is contract SPE2DB26FM8RL an order under another contract?
Yes. SPE2DB26FM8RL is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB26FM8RL competed?
The extent of competition for SPE2DB26FM8RL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award